Artiva Biotherapeutics, Inc To Start Trading Tomorrow
Artiva Biotherapeutics, Inc To Start Trading Tomorrow
Artiva Biotherapeutics, Inc (NASDAQ:ARTV) IPO will take place July, 19 on the NASDAQ exchange under the ticker ARTV.
Artiva Biotherapeutics，Inc（納斯達克：ARTV）的IPO將於7月19日在納斯達克交易所上市，代號爲ARTV。
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on January 15, 2025.
該公司發行股票的期望價格爲每股14.00美元至16.00美元，內部人士鎖定期爲180天，截至2025年1月15日。
See also: Benzinga IPO Calendar
參見：Benzinga IPO日曆
About Artiva Biotherapeutics, Inc
關於Artiva Biotherapeutics，Inc
Artiva Biotherapeutics, Inc is a clinical-stage biotechnology company focused on developing NK cell-based therapies for patients suffering from devastating autoimmune diseases and cancers.
Artiva Biotherapeutics，Inc是一家臨床階段的生物技術公司，專注於開發基於Nk細胞的治療方案，用於治療患有嚴重自身免疫性疾病和癌症的患者。
See also: Benzinga's Most Shorted Stocks
參見：Benzinga的做空集合股
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動化內容引擎生成並由編輯審查。